CRVO – cervomed inc. (US:NASDAQ)
Stock Stats
News
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
CervoMed (NASDAQ:CRVO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
Form SCHEDULE 13G CervoMed Inc. Filed by: MORGAN STANLEY
Form 8-K CervoMed Inc. For: Jan 07
Form 4 CervoMed Inc. For: Oct 27 Filed by: Quigley David
Form 3 CervoMed Inc. For: Oct 27 Filed by: Quigley David
Form 8-K CervoMed Inc. For: Dec 01
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.